Abstract | AIM: METHODS: We invited 166 children who were hospitalised for bronchiolitis at younger than 6 months of age to follow-up visits at 5-7 years and 11-13 years of ages. Asthma and allergy diagnoses, asthma-presumptive symptoms and use of inhaled corticosteroids (ICSs) were registered. Blood samples were available for IL17F rs763780 (T/C), rs11465553 (C/T) and rs7741835 (C/T) determinations in 165 cases. RESULTS: The presence of IL17F rs11465553 and rs7741835 variations showed no significant associations with any asthma or allergy outcome at either 5-7 years or 11-13 years of ages. Instead, children with the variant IL17F rs763780 genotype had used more often ICSs between the follow-up visits from 5-7 to 11-13 years (adjusted OR 3.58) than those with the wild genotype. Children with the variant IL17F rs763780 genotype reported more often doctor-diagnosed atopic dermatitis (adjusted OR 2.71) at 11-13 years of age than those with the wild genotype. CONCLUSION: This prospective long-term follow-up study provided preliminary evidence on the association of the IL17F rs763780 polymorphism with asthma at school age after bronchiolitis in infancy.
|
Authors | Annukka Holster, Johanna Teräsjärvi, Alex-Mikael Barkoff, Eero Lauhkonen, Sari Törmänen, Merja Helminen, Matti Korppi, Qiushui He, Kirsi Nuolivirta |
Journal | Acta paediatrica (Oslo, Norway : 1992)
(Acta Paediatr)
Vol. 110
Issue 1
Pg. 222-227
(01 2021)
ISSN: 1651-2227 [Electronic] Norway |
PMID | 32495451
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2020 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd. |
Chemical References |
- IL17F protein, human
- Interleukin-17
|
Topics |
- Asthma
(genetics)
- Bronchiolitis
(genetics)
- Child
- Follow-Up Studies
- Genetic Predisposition to Disease
- Genotype
- Humans
- Infant
- Interleukin-17
(genetics)
- Polymorphism, Single Nucleotide
- Prospective Studies
|